Cargando…

Advanced Molecular Characterisation in Relapsed and Refractory Paediatric Acute Leukaemia, the Key for Personalised Medicine

Relapsed and refractory (R/r) disease in paediatric acute leukaemia remains the first reason for treatment failure. Advances in molecular characterisation can ameliorate the identification of genetic biomarkers treatment strategies for this disease, especially in high-risk patients. The purpose of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galán-Gómez, Víctor, Matamala, Nerea, Ruz-Caracuel, Beatriz, Valle-Simón, Paula, Ochoa-Fernández, Bárbara, Guerra-García, Pilar, Pernas-Sánchez, Alicia, Minguillón, Jordi, González, Berta, Martínez-Romera, Isabel, San Román-Pacheco, Sonsoles, Estival-Monteliú, Pablo, Ibáñez-Navarro, Adrián, Pérez-Martínez, Antonio, Escudero-López, Adela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224967/ https://www.ncbi.nlm.nih.gov/pubmed/35743666 http://dx.doi.org/10.3390/jpm12060881

Ejemplares similares

Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy
por: Fernández, Adrián, et al.
Publicado: (2021)

CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation
por: Martínez-Romera, Isabel, et al.
Publicado: (2022)

Molecular techniques for the personalised management of patients with chronic myeloid leukaemia
por: Alikian, Mary, et al.
Publicado: (2017)

A personalised medicine approach for ponatinib-resistant chronic myeloid leukaemia
por: Korfi, K., et al.
Publicado: (2015)

The clinical characterisation of the patient with primary psychosis aimed at personalisation of management
por: Maj, M.
Publicado: (2021)

Survivin’ Acute Myeloid Leukaemia—A Personalised Target for inv(16) Patients
por: Greiner, Jochen, et al.
Publicado: (2021)

Younger age and induction failure predict outcomes in infant leukemia: 30 years of experience in a tertiary center
por: Ochoa-Fernández, Bárbara, et al.
Publicado: (2023)

Stroke secondary to leptomeningeal carcinomatosis with radiologic signs of arterial invasion
por: Gutiérrez, María López, et al.
Publicado: (2022)

Personalised, population and planetary nutrition for precision health
por: Martínez-González, Miguel A, et al.
Publicado: (2021)

Immunophenotypic characterisation of morphologically diagnosed cases of Acute Myeloid Leukaemia (AML)
por: Basharat, Maria, et al.
Publicado: (2019)

Characterising experiences with acute myeloid leukaemia using an Instagram content analysis
por: Parker, Catriona, et al.
Publicado: (2021)

P1428: IMPLICATIONS OF THE RUXOLITINIB (JAK1/JAK2 INHIBITOR) ON GRAFT-VERSUS-LEUKAEMIA EFFECT MEDIATED BY THE NK CELL.
por: Durán, C., et al.
Publicado: (2022)

NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells
por: Ibáñez-Navarro, Marta, et al.
Publicado: (2023)

Subcutaneous Radiographic Measurement: A Marker to Evaluate Surgical Site Infection Risk in Elderly Hip Fracture Patients
por: Bernaus, Martí, et al.
Publicado: (2019)

Personalised diet
Publicado: (2011)

Personalised Ecology
por: Gaston, Kevin J., et al.
Publicado: (2018)

NAFLD and AATD Are Two Diseases with Unbalanced Lipid Metabolism: Similarities and Differences
por: Perez-Luz, Sara, et al.
Publicado: (2023)

JOCR: Personalised Journal, Personalised Network and Clinical Decision Making (CDM)
por: Shyam, Ashok
Publicado: (2012)

Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia
por: Muñoz Builes, Mario, et al.
Publicado: (2020)

Personalised nutrition and health
por: Ordovas, Jose M, et al.
Publicado: (2018)

Personalised Medicine in Europe
por: Andriukaitis, Vytenis
Publicado: (2017)

Toward self big data
por: Saqr, Mohammed, et al.
Publicado: (2021)

Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome
por: Bojesen, S E, et al.
Publicado: (2006)

Virome characterisation from Guthrie cards in children who later developed acute lymphoblastic leukaemia
por: Bogdanovic, G, et al.
Publicado: (2016)

Other side of the coin for personalised medicine and healthcare: content analysis of ‘personalised’ practices in the literature
por: Cesuroglu, Tomris, et al.
Publicado: (2016)

Review of Technological Challenges in Personalised Medicine and Early Diagnosis of Neurodegenerative Disorders
por: Domínguez-Fernández, Celtia, et al.
Publicado: (2023)

Personalised Nutritional Plan and Resistance Exercise Program to Improve Health Parameters in Celiac Women
por: Martínez-Rodríguez, Alejandro, et al.
Publicado: (2022)

Leukæmia and Pseudo-Leukæmia
Publicado: (1877)

Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture
por: Conte, N, et al.
Publicado: (2013)

Introduction to sessions on Personalising treatment
por: Dowsett, Mitch, et al.
Publicado: (2007)

The Promise and the Hype of ‘Personalised Medicine’
por: Maughan, Tim
Publicado: (2017)

Keeping the Person in Personalised Healthcare
por: Horgan, Denis
Publicado: (2017)

What is the promise of personalised nutrition?
por: Ferrario, Paola G., et al.
Publicado: (2021)

Dynamic consent and personalised medicine
por: Goncharov, Liza, et al.
Publicado: (2022)

Personalised medicine: are we ready?
por: Louis, Renaud, et al.
Publicado: (2017)

Personalised pulmonary rehabilitation in COPD
por: Wouters, Emiel F.M., et al.
Publicado: (2018)

Pharmacogenomics in the era of personalised medicine
por: White, Cassandra, et al.
Publicado: (2022)

Insights into Personalised Medicine in Bronchiectasis
por: Fraser, Clementine S., et al.
Publicado: (2023)

Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation
por: Russo, Ilaria J., et al.
Publicado: (2018)

Immunotherapy in leukaemia: Immunotherapy in leukaemia
por: Mu, Xingmei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o0jig3vr9lsgi46g7loldg4a48